Stride
140 hedge funds and large institutions have $546M invested in Stride in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 61 increasing their positions, 41 reducing their positions, and 14 closing their positions.
671% more call options, than puts
Call options by funds: $1.13M | Put options by funds: $147K
49% more repeat investments, than reductions
Existing positions increased: 61 | Existing positions reduced: 41
12% more capital invested
Capital invested by funds: $486M → $546M (+$59.7M)
0% more funds holding
Funds holding: 140 → 140 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
1.79% less ownership
Funds ownership: 82.74% → 80.95% (-1.8%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$6.44M |
| 2 |
State Street
Boston,
Massachusetts
|
+$4.8M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$3.87M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$3.36M |
| 5 |
Millennium Management
New York
|
+$2.89M |
Top Sellers
LRN Hedge Fund Activity: Q2 2018 in Review
140 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Stride (LRN) for Q2 2018, worth a combined $546M — up 12% from $486M a quarter earlier.
Fund positioning in LRN was balanced in Q2 2018: 14 funds opened new positions, 14 closed out, 61 added to existing stakes and 41 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $6.44M. The largest seller was Technology Crossover Management VII, exiting entirely with an estimated $39.3M sold.
- 140 institutional investors held Stride (LRN) as of Q2 2018, unchanged from Q1 2018.
- Funds reported $546M of Stride stock for Q2 2018, up 12% quarter-over-quarter.
- 14 funds opened new Stride positions in Q2 2018 and 14 closed out, a net change of 0 holders.
- The largest Stride buyer in Q2 2018 was Morgan Stanley, an estimated $6.44M added.
- The largest Stride seller in Q2 2018 was Technology Crossover Management VII, an estimated $39.3M sold.
Based on aggregated 13F filings for Q2 2018.